Click a link below to view the mailing archive as if it had been sent to you.
| 2019-05-31 12:15 | | ASCO 2019 day one and more... |
| 2019-05-31 00:15 | | Follow the money: How biopharma CEOs and workers got paid in 2018 and more... |
| 2019-05-30 12:15 | | Novartis burnishes prospects for its big asthma drug with positive PhIII data from a similar treatment and more... |
| 2019-05-30 00:15 | | Bayer to work with Foundation Medicine on selecting cancer patients and more... |
| 2019-05-29 12:15 | | GSK prevails in Paxil preemption case as Supreme Court refuses review and more... |
| 2019-05-29 00:15 | | How BioMarin May Revolutionize the Hemophilia Treatment Market and more... |
| 2019-05-28 12:15 | | Even as obesity rates climb, new diabetes cases fall and more... |
| 2019-05-28 00:15 | | Deep Learning Algorithms Are Expected To Boost Liquid Biopsy Techniques and more... |
| 2019-05-27 10:55 | | CP Microbiome Report wk ending 5-25-19 |
| 2019-05-26 12:15 | | Novartis gets FDA nod for advanced breast-cancer treatment and more... |
| 2019-05-25 00:15 | | Novartis gene therapy approved, but will come at cost of more than $2 million and more... |
| 2019-05-24 12:15 | | US Crackdown On Foreign Biotech Investment Makes Us Poorer, Not Safer and more... |
| 2019-05-24 00:15 | | Affimed scraps T-cell engager program, parts company with CSO and more... |
| 2019-05-23 12:15 | | UPDATED: Sarepta's Exondys 51 is not cost-effective, nor particularly beneficial for DMD patients — ICER and more... |
| 2019-05-23 00:15 | | mRNA and Artificial Intelligence: An Interview with AnimaBiotech’s Yochi Slonim and more... |
| 2019-05-22 12:15 | | Amgen offers $167m for drug discovery biotech Nuevolution and more... |
| 2019-05-22 00:15 | | Verily lures major pharmas with promise of speedier clinical research and more... |
| 2019-05-21 14:07 | | CP Microbiome Report wk ending 5-18-19 |
| 2019-05-21 12:15 | | AstraZeneca says Symbicort as anti-inflammatory reliever reduces attacks in mild asthma and more... |
| 2019-05-21 00:15 | | Reneo Pharma Launches with $50M to Target Energy-Depleting Diseases and more... |
| 2019-05-20 12:15 | | Industry steps up interest in developing world, fueling doubling of R&D pipeline and more... |
| 2019-05-20 00:15 | | Top 5 New Drug Launches of 2019 -- and the Biotech Stocks That Could Win Big and more... |
| 2019-05-19 00:15 | | Digital Medicine: Digital Health, Plus Evidence, Plus Humility and more... |
| 2019-05-18 00:15 | | Focus on specialty drugs reflects ‘cyclical nature’ of biopharma, industry veteran says and more... |
| 2019-05-17 12:15 | | AbbVie stock down 1.8% in premarket trade after failure of glioblastoma drug trial and more... |
| 2019-05-17 00:15 | | Evolus sparks controversy with Cancun beach bash ahead of Jeuveau launch and more... |
| 2019-05-16 14:08 | | CP Microbiome Report wk ending 5-11-19 |
| 2019-05-16 12:15 | | Can a little known drug in AstraZeneca's pipeline make a comeback as a PARP add-on? Yale scientists explain how and more... |
| 2019-05-16 00:15 | | May 15 ASCO Quick Takes: After-hours pop for Iovance, MacroGenics; plus Takeda, Amgen, Forty Seven and more... |
| 2019-05-15 12:15 | | Daiichi Sankyo Takes Two Products to FDA Advisory Panel; Gets One Yes, One No and more... |
| 2019-05-15 00:15 | | Will a big needle burst the NASH bubble? and more... |
| 2019-05-14 12:15 | | What's taking the FTC so long? Roche won't say, but insists it will bag Spark on time — despite third delay and more... |
| 2019-05-14 00:15 | | Medtronic, Boston Scientific unveil ICD data and more... |
| 2019-05-13 12:15 | | Google Jumps Into Gene Editing: 5 Things You Need to Know and more... |
| 2019-05-13 00:15 | | 3 Key Takeaways From Portola Pharmaceuticals' Quarterly Results and more... |
| 2019-05-12 00:15 | | The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs and more... |
| 2019-05-11 00:15 | | New Eisai venture arm to focus on digital tech, dementia, cancer and more... |
| 2019-05-10 12:15 | | Xencor begins phase 1 trial of XmAb23104 in advanced solid tumors and more... |
| 2019-05-10 00:15 | | Gilead will donate meds for US push to end HIV epidemic and more... |
| 2019-05-09 12:15 | | Takeda sells Shire’s Xiidra, transfers 400 staffers to Novartis in $3.4B deal and more... |
| 2019-05-09 00:15 | | Eli Lilly's Emgality shows positive Phase 3 results in treatment of migraine and more... |
| 2019-05-08 15:45 | | CP Microbiome Report wk ending 5-4-19 |
| 2019-05-08 12:15 | | Amarin defends Vascepa's CV-prevention data against supplement makers eager to cash in and more... |
| 2019-05-08 00:15 | | Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings and more... |
| 2019-05-07 12:15 | | FDA to Study DTC Ads for Drugs Approved Under Accelerated Process and more... |
| 2019-05-07 00:15 | | New Zolgensma data suggest comparable efficacy to Spinraza — analysts and more... |
| 2019-05-06 12:15 | | Riding high after its IPO, Moderna chief nabs $59M, biopharma's biggest 2018 paycheck and more... |
| 2019-05-06 00:15 | | Cytokinetics' comeback attempt with second-gen drug is slammed by a PhII failure in ALS and more... |
| 2019-05-05 12:15 | | Eisai Continues Alzheimer's Research, Adds 2 Alzheimer's Pros as Execs and more... |
| 2019-05-05 00:15 | | At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments and more... |
| 2019-05-04 00:15 | | Highlights: American Society of Gene & Cell Therapy Meeting and more... |
| 2019-05-03 12:15 | | FDA approves AstraZeneca's triple combination therapy for type 2 diabetes and more... |
| 2019-05-03 00:15 | | Should Patients Have a Say in Medical Device Regulatory Matters? and more... |
| 2019-05-02 16:57 | | CP Microbiome Report wk ending 4-27-19 |
| 2019-05-02 12:15 | | These 6 biotech stocks are promising takeover targets and more... |
| 2019-05-02 00:15 | | FDA approves the first vaccine for dengue fever, but with major restrictions and more... |
| 2019-05-01 12:15 | | Keytruda drives another strong Merck quarter, but what’s next? and more... |
| 2019-05-01 00:15 | | CMS reopens coverage determination on next-gen sequencing for cancer patients and more... |
